Search Results

There are 64689 results for: content related to: Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. Hepatitis C

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt033

  3. You have free access to this content
    Guidelines for the Management of Hepatitis C Virus Infection

    Hepatology Research

    Volume 43, Issue 1, January 2013, Pages: 1–34, Editors of the Drafting Committee for Hepatitis Management Guidelines: The Japan Society of Hepatology

    Version of Record online : 18 JAN 2013, DOI: 10.1111/hepr.12020

  4. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2014 Update for Genotype 1

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 59–70, Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12272

  5. You have free access to this content
    Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: A randomized controlled trial

    Hepatology

    Volume 50, Issue 4, October 2009, Pages: 1045–1055, Stuart K. Roberts, Martin D. Weltman, Darrell H. G. Crawford, Geoffrey W. McCaughan, William Sievert, Wendy S. Cheng, William Rawlinson, Paul V. Desmond, Phillipa S. Marks, Motoko Yoshihara, Bishoy Rizkalla, Jean K. DePamphilis, Gregory J. Dore and Chariot Study Group

    Version of Record online : 15 JUN 2009, DOI: 10.1002/hep.23130

  6. Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)

    Hepatology Research

    Volume 40, Issue 4, April 2010, Pages: 347–368, Izumi Namiki, Shuhei Nishiguchi, Keisuke Hino, Fumitaka Suzuki, Hiromitsu Kumada, Yoshihito Itoh, Yusuhiro Asahina, Akihiro Tamori, Naoki Hiramatsu, Norio Hayashi and Masatoshi Kudo

    Version of Record online : 29 MAR 2010, DOI: 10.1111/j.1872-034X.2010.00642.x

  7. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  8. Direct-acting antivirals for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Janus C Jakobsen, Emil Eik Nielsen, Joshua Feinberg, Kiran Kumar Katakam, Kristina Fobian, Goran Hauser, Goran Poropat, Snezana Djurisic, Karl Heinz Weiss, Milica Bjelakovic, Goran Bjelakovic, Sarah Louise Klingenberg, Jian Ping Liu, Dimitrinka Nikolova, Ronald L Koretz and Christian Gluud

    Published Online : 6 JUN 2017, DOI: 10.1002/14651858.CD012143.pub2

  9. Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis

    Liver International

    Volume 31, Issue 3, March 2011, Pages: 401–411, Sanaa M. Kamal, Amany Ahmed, Sara Mahmoud, Leila Nabegh, Iman El Gohary, Isi Obadan, Tamer Hafez, Dahlia Ghoraba, Ahmed A. Aziz and Mona Metaoei

    Version of Record online : 11 JAN 2011, DOI: 10.1111/j.1478-3231.2010.02435.x

    Corrected by:

    CORRIGENDA

    Vol. 31, Issue 4, 588, Version of Record online: 17 FEB 2011

  10. Growth inhibitory effects of pegylated IFN α-2b on human liver cancer cells in vitro and in vivo

    Liver International

    Volume 26, Issue 8, October 2006, Pages: 964–975, Hirohisa Yano, Sachiko Ogasawara, Seiya Momosaki, Jun Akiba, Sakiko Kojiro, Suguru Fukahori, Hironori Ishizaki, Keitaro Kuratomi, Yuji Basaki, Shinji Oie, Michihiko Kuwano and Masamichi Kojiro

    Version of Record online : 10 AUG 2006, DOI: 10.1111/j.1478-3231.2006.01321.x

  11. Expert recommendations on the application of interferon for chronic hepatitis B

    Journal of Digestive Diseases

    Volume 14, Issue 12, December 2013, Pages: 626–637, Mo Bin Wan and Xin Hua Weng

    Version of Record online : 5 NOV 2013, DOI: 10.1111/1751-2980.12096

  12. Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

    Journal of Viral Hepatitis

    Volume 19, Issue 9, September 2012, Pages: 623–634, S. Pianko, S. Zeuzem, W.-L. Chuang, G. R. Foster, S. K. Sarin, R. Flisiak, C.-M. Lee, P. Andreone, T. Piratvisuth, S. Shah, A. Sood, J. George, M. Gould, P. Komolmit, S. Thongsawat, T. Tanwandee, J. Rasenack, Y. Li, M. Pang, Y. Yin, G. Feutren, I. M. Jacobson and for the B2202 Study Team

    Version of Record online : 21 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01586.x

  13. You have free access to this content
    Pharmacokinetics and response of obese patients with chronic hepatitis C treated with different doses of PEG-IFN α-2a (40KD) (PEGASYS®)

    British Journal of Clinical Pharmacology

    Volume 67, Issue 3, March 2009, Pages: 280–287, Brian Bressler, Ka Wang, Joseph F. Grippo and E. Jenny Heathcote

    Version of Record online : 20 MAR 2009, DOI: 10.1111/j.1365-2125.2008.03349.x

  14. Peginterferon α-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients

    Journal of Gastroenterology and Hepatology

    Volume 22, Issue 5, May 2007, Pages: 645–652, Makoto Kuboki, Shiro Iino, Tadao Okuno, Masao Omata, Kendo Kiyosawa, Hiromitsu Kumada, Norio Hayashi and Takahiro Sakai

    Version of Record online : 7 FEB 2007, DOI: 10.1111/j.1440-1746.2007.04834.x

  15. You have free access to this content
    Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: A randomized phase II study

    Hepatology

    Volume 56, Issue 3, September 2012, Pages: 884–893, Michael P. Manns, Edward Gane, Maribel Rodriguez-Torres, Albrecht Stoehr, Chau-Ting Yeh, Patrick Marcellin, Richard T. Wiedmann, Peggy M. Hwang, Luzelena Caro, Richard J.O. Barnard, Andrew W. Lee and for the MK-7009 Protocol 007 Study Group

    Version of Record online : 17 JUL 2012, DOI: 10.1002/hep.25743

  16. You have free access to this content
    Review article: novel therapeutic options for chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 10, May 2008, Pages: 866–884, E. CHOLONGITAS and G. V. PAPATHEODORIDIS

    Version of Record online : 12 FEB 2008, DOI: 10.1111/j.1365-2036.2008.03644.x

  17. Pegylated α-interferon-2a plus ribavirin compared with pegylated α-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: Prospective, non-randomized study

    Journal of Gastroenterology and Hepatology

    Volume 23, Issue 6, June 2008, Pages: 861–866, Amparo Escudero, Felicidad Rodríguez, Miguel A Serra, Juan A Del Olmo, Francisco Montes and José M Rodrigo

    Version of Record online : 19 APR 2008, DOI: 10.1111/j.1440-1746.2008.05397.x

  18. Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma

    Journal of the European Academy of Dermatology and Venereology

    Volume 26, Issue 1, January 2012, Pages: 71–78, A.C. Hüsken, A. Tsianakas, P. Hensen, D. Nashan, C. Loquai, S. Beissert, T.A. Luger, C. Sunderkötter and M. Schiller

    Version of Record online : 9 MAR 2011, DOI: 10.1111/j.1468-3083.2011.04011.x

  19. Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue 9, September 2012, Pages: 640–649, E. Villa, C. Cammà, A. Di Leo, A. Karampatou, M. Enea, S. Gitto, V. Bernabucci, L. Losi, N. De Maria, B. Lei, A. Ferrari, R. Vukotic, P. Vignoli, M. Rendina and A. Francavilla

    Version of Record online : 15 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01593.x

  20. You have free access to this content
    Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C

    Hepatology

    Volume 48, Issue 2, August 2008, Pages: 407–417, Stefan Zeuzem, Eric M. Yoshida, Yves Benhamou, Stephen Pianko, Vincent G. Bain, Daniel Shouval, Robert Flisiak, Vratislav Rehak, Mircea Grigorescu, Kelly Kaita, Patrick W. Cronin, Erik Pulkstenis, G. Mani Subramanian and John G. McHutchison

    Version of Record online : 9 MAY 2008, DOI: 10.1002/hep.22403